Home/Filings/4/0001384101-24-000180
4//SEC Filing

Chambers Rebecca 4

Accession 0001384101-24-000180

CIK 0001384101other

Filed

Dec 3, 7:00 PM ET

Accepted

Dec 4, 4:59 PM ET

Size

7.0 KB

Accession

0001384101-24-000180

Insider Transaction Report

Form 4
Period: 2024-12-02
Chambers Rebecca
Chief Financial Officer
Transactions
  • Sale

    Common Stock

    2024-12-03$43.23/sh7,000$302,622114,037 total
  • Tax Payment

    Common Stock

    2024-12-02$44.12/sh3,464$152,832121,037 total
Footnotes (3)
  • [F1]The reporting person is reporting the withholding of 1,077, 657, 905 and 825 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,125, 1,295, 1,784 and 1,626 Restricted Stock Units granted on July 19, 2021, March 3, 2022 , August 5, 2022, and March 6, 2023, respectively, and does not represent a sale by the reporting person.
  • [F2]The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 13, 2024.
  • [F3]Represents weighted average sales price. Sale prices for the transactions range from $42.71 to $43.64. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

Issuer

VERACYTE, INC.

CIK 0001384101

Entity typeother

Related Parties

1
  • filerCIK 0001823563

Filing Metadata

Form type
4
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 4:59 PM ET
Size
7.0 KB